Completed OBSERVATIONAL NCT05788172

Measuring Menstrual Iron Loss Using the Iron Isotope Dilution Technique (MBL_Loss)

Quantifying Menstrual Blood Loss: Validating the Methodology for Stable Iron Isotopes Dilution Against the Alkaline Hematin Method

Sponsor: Isabelle Herter-Aeberli

Conditions Anemia Iron-deficiency Menorrhagia

Interventions Alkaline hematin method Iron isotope dilution

Updated 4 times since 2023 Last updated: Nov 21, 2023 Started: Mar 1, 2023 Primary completion: Jun 29, 2023 Completion: Aug 30, 2023

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT05788172, this observational or N/A phase trial focuses on Anemia and Iron-deficiency and remains completed. Sponsored by Isabelle Herter-Aeberli, it has been updated 4 times since 2023, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Dec 2023 — Jul 2024 [monthly]

Completed

Status: Active Not Recruiting → Completed
Apr 2023 — Dec 2023 [monthly]

Active Not Recruiting

First recorded

Mar 2023

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Isabelle Herter-Aeberli
Kamuzu University of Health Sciences
Sight and Life Foundation
Wageningen University and Research

Data source: Swiss Federal Institute of Technology

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Zurich, Switzerland